Subscribe to Daily Review - your favourite M&A deals update.

Submit Deal

Bruce Voss

Managing Director at LHA Investor Relations

PR Consultant

Deal Bio

Total Deals5

Valued Deals5

Total Value£ 1.48 B

Avg. Deal Size£ 295 M

Market Context

Sort

23 Mar 2022|United States|Biotechnology

Target: OMNIAB INC

Bidder: AVISTA PUBLIC ACQUISITION CORP II

15 Service Providers

9 Target | 3 Bidder | 3 Vendor

37 Dealmakers

5 Target | 25 Bidder | 7 Vendor

£ 643 M

Value

18 Jan 2022|United States|Biotechnology

Target: GENEDX

Bidder: SEMA4

11 Service Providers

1 Target | 5 Bidder | 5 Vendor

34 Dealmakers

3 Target | 25 Bidder | 6 Vendor

£ 455 M

Value

12 Oct 2020|United Kingdom|Biotechnology

Target: VERNALIS (RESEARCH & DEVELOPMENT UNIT)

Bidder: HITGEN INC

4 Service Providers

1 Bidder | 3 Vendor

5 Dealmakers

1 Bidder | 4 Vendor

£ 19 M

Value

10 Aug 2020|United States|Biotechnology

Target: PFENEX INC

Bidder: LIGAND PHARMACEUTICALS INC

7 Service Providers

3 Target | 4 Bidder

13 Dealmakers

5 Target | 8 Bidder

£ 349 M

Value

23 Jul 2019|United States|Biotechnology

Target: AB INITIO BIOTHERAPEUTICS

Bidder: LIGAND PHARMACEUTICALS INC

2 Service Providers

1 Target | 1 Bidder

4 Dealmakers

1 Target | 3 Bidder

£ 9 M

Value

Explore deals beyond your search with a free MergerLinks account.

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy